The approved uses of this class are type 2 diabetes, chronic weight management, and, for several agents, reduction of cardiovascular risk
The key differences are in the types of medications offered, dosing flexibility, and how much behavioral support accompanies treatment
The Journal of Clinical Endocrinology and Metabolism
3.2 Bi ton hiu qu thc t Nu bn ung 2000mg nhng c th ch nhn c mt phn nh (phn cn li b o thi gy p lc cho gan), th vic dng vin ngm 100mg vi kh nng hp th cao s mang li hiu qu thc t v t gy lng ph hn
States such as New York, Pennsylvania, Michigan, Massachusetts, and Colorado currently cover Wegovy through Medicaid with prior authorization
References 1 American Medical Association